menu close
Access The Private Market

Explore Companies

With a comprehensive suite of private market programming and liquidity solutions, Nasdaq Private Market can help unlock the power of data for market participants worldwide.

Pathai-Logo

PathAI

The leading provider of AI-powered technology for pathology.

Peel Therapeutics

Biotech company develops cancer and inflammatory disease treatments by studying evolutionary adaptations in nature's biological outliers.

Pharmazz

Develops therapeutics that restore critical care functions through innovative endothelin‑based drug mechanisms.

Pillar Biosciences

Develops molecular diagnostic tools and genomic testing solutions to enable precision medicine and personalized treatment in clinical settings.

Pivot Bio-Logo

Pivot Bio

Developed a new in-field solution to biological nitrogen fixation for farmer, providing daily crop feeding without leaching, volatilization, or denitrification.

Pneuma

Harnessing microorganisms, the company creates living materials that evolve and adapt through bioinspired engineering.

Precision Neuro

Specializes in the development of minimally invasive brain–computer interface (BCI) technology.

Pretzel Therapeutics

Pioneering therapies that restore mitochondrial bioenergetics to target degenerative and metabolic conditions via enzyme activation and DNA modulation.

PrognomIQ

Develops advanced tests combining proteomic, genomic, and metabolomic data for early disease detection and treatment.

Q32 Bio

Develops biologic therapeutics targeting key immune regulators, aiming to restore balance in autoimmune and inflammatory diseases.

Quanta Therapeutics

Therapeutics for conformational blockade of RAS in cancer.

Rakuten Medical-Logo

Rakuten Medical

Developing precision, cell-targeting investigational therapies on its Illuminox platform, which have shown rapid and selective cell killing and tumor necrosis in pre-clinical studies.

RayzeBio

Develops targeted radiopharmaceutical therapies to treat solid tumors and metastatic cancers through precise intravenous delivery.

ReCode Therapeutics

Developing precision medicines for genetic respiratory diseases.

Rectify Pharma

Develops oral small molecule therapeutics targeting membrane protein dysfunction to treat chronic diseases and disorders.

Remix Therapeutics

Develops small molecule therapies targeting RNA processing to treat diseases, using proprietary technology for cancer and genetic disorder treatments.

Renasant Bio

Develops compounds that target genetic kidney disease pathways to halt progression with innovative oral therapies.

Weareresilience-Logo

Resilience

Operates as technology-focused biomanufacturing company dedicated to broadening access to complex medicines.